Goldstein DP, Berkowitz RS. Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol 1995;22:157–160.
36.
Kim DS, Moon H, Kim KT, et al. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol 1986;67:690–694.
37.
Limpongsanurak S. Prophylactic actinomycin D for high-risk complete hydatidiform mole. J Reprod Med 2001;46:110–116.
38.
Uberti EMH, Fajardo Mde C, da Cunha AGV, et al. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low cost approach without adverse effects on compliance to general follow-up or subsequent treatment. Gynecol Oncol 2009;114:299–305.
39.
Committee on Practice Bulletins-Gynecology. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin 53. Diagnosis and treatment of gestational trophoblastic neoplasms. Obstet Gynecol 2004;103:1365–1373.
40.
Genest DR, LaBorde O, Berkowitz RS, et al. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980– 1990): histologic grade lacks prognostic significance. Obstet Gynecol 1991;78:402–409.
41.
Wolfberg A, Feltmate C, Goldstein DP, et al. Low risk of relapse after achieving undetectable hCG levels in women with complete molar pregnancy. Obstet Gynecol 2004;104:551–554.
42.
Lavie I, Rao G, Castrillon DH, et al. Duration of human chorionic gonadotropin surveillance or partial hydatidiform moles. Am J Obstet Gynecol 2005;192:1362–1364.
43.
Sebire NJ, Foskett M, Short D, et al. Shortened duration of human chorionic gonadotropin surveillance following complete or partial hydatidiform mole: evidence for a revised protocol of a regional UK trophoblastic disease unit. Br J Obstet Gynaecol 2007;114:760–762.
44.
Stone M, Dent J, Kardana A, et al. Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole. BJOG 1976;83:913–916.
45.
Berkowitz RS, Goldstein DP, Marean AR, et al. Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol 1981;58:474– 477.
46.
Curry SL, Schlaerth JB, Kohorn EI, et al. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1989;160:805–809.
47.
Parrazzini F, Cipriani S, Mangili G, et al. Oral contraceptives and risk of gestational trophoblastic disease. Contraception 2002;65:4257.
48.